TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Angarns Bio AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,091
|
2,655
|
2,219 |
| Financial expenses |
33
|
22
|
2 |
| Earnings before taxes |
2,793
|
2,428
|
1,575 |
| EBITDA |
2,899
|
2,538
|
1,719 |
| Total assets |
19,904
|
18,773
|
16,429 |
| Current assets |
2,612
|
1,247
|
660 |
| Current liabilities |
796
|
1,638
|
969 |
| Equity capital |
19,108
|
16,992
|
15,317 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
96.0%
|
90.5%
|
93.2% |
| Turnover per employee |
3,091
|
2,655
|
2,219 |
| Profit as a percentage of turnover |
90.4%
|
91.5%
|
71.0% |
| Return on assets (ROA) |
14.2%
|
13.1%
|
9.6% |
| Current ratio |
328.1%
|
76.1%
|
68.1% |
| Return on equity (ROE) |
14.6%
|
14.3%
|
10.3% |
| Change turnover |
436
|
436
|
-876 |
| Change turnover % |
16%
|
20%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.